Feng-Ming Wang

CEO Feng-Ming Wang sold 16,250 shares of AMBA at $90.08 on 2026-07-01 via pre-arranged 10b5-1 plan; current price $78.36

This sale by CEO Feng-Ming Wang of 16,250 shares (16.2K shares) for $1,463,800.00 ($1.5M) was executed under a pre-arranged 10b5-1 trading plan adopted on 2025-10-08, making it a scheduled transaction rather than a discretionary choice. The sale occurred at $90.08, while the current price stands at $78.36, representing a -19.0% decline from the 52-week high of $96.69. AMBA faces fundamental headwinds: the company posted net income of $-18,093,000.00 ($-18.1M) in its most recent full fiscal year, though revenue grew +37.2% year-over-year to $100,357,000.00 ($100.4M) in the latest quarter. The CEO's post-transaction holdings of 773,607 shares (773.6K shares) represent a -2.1% reduction from his pre-transaction position of 789,857 shares (789.9K shares), maintaining substantial retained exposure to the company.

CEO Feng-Ming Wang executes 3 scheduled sales totaling 32,500 shares for $2,957,754.66 under 10b5-1 plan; holds 806,061 shares post-transaction.

Feng-Ming Wang sold 32,500 shares across three transactions on 2026-05-26 at an average price of $91.01, executing a pre-arranged 10b5-1 trading plan adopted 2025-10-08. This sale reduces his holdings from 838,561 shares to 806,061 shares (-3.9% vs pre-transaction holdings). The transaction occurs at current price $91.84, which is -5.0% from the 52-week high of $96.69. Over the same 30-day period, AMBA's stock has appreciated +44.1%, though at the CEO level, AMBARELLA remains unprofitable with net income of $-15,107,000.00 in the latest quarter despite annual revenue growth of +37.2%. The scheduled nature of this sale under a 10b5-1 plan removes discretionary timing considerations from the transaction.

CEO Wang Feng-Ming sold 27,059 shares for $1,438,977.14 as stock down 23.0% in 90 days; AMBA unprofitable with $-15.1M net income.

CEO Wang Feng-Ming executed 2 separate sales totaling 27,059 shares (27.1K shares) for $1,438,977.14 at a blended average price of $53.18 on 2026-03-17 and 2026-03-19, reducing his holdings by 3.1% to 838,561 shares. The sales occurred against a backdrop of significant stock weakness: AMBA is -41.5% from its 52-week high and -23.0% over the prior 90 days. Most critically, the company is unprofitable, posting a net loss of $-15.1M in its latest full fiscal year despite 25.8% annual revenue growth. Wang's own cross-ticker track record shows a 0.00% well-timed sell rate, meaning his prior 7 open-market sales across all holdings have not historically preceded stock declines. The recent 5 prior sales at AMBA (all on 2026-03-02, just 15 days before this filing) remain unmeasurable at the 90-day mark, offering no pattern clarity at this ticker. The combination of accelerating sales activity and deteriorating stock fundamentals against negative profitability warrants investor scrutiny.

CEO Wang Feng-Ming sold 50,000 shares at blended average $60.80 (total $3.0M) via pre-arranged 10b5-1 plan on 2026-03-02.

CEO Wang Feng-Ming executed 5 separate sales totaling 50,000 shares for $3,040,031.32 on 2026-03-02, reducing holdings from 872,182 shares to 822,182 shares (-5.7%). The transaction was part of a pre-arranged 10b5-1 trading plan adopted on 2025-10-08, meaning it was scheduled rather than discretionary. Since the sales were structured under a 10b5-1 plan, they do not reflect timing decisions made at the point of execution. The magnitude of the sale (50.0K shares) represents a meaningful portfolio reduction for the CEO, though the scheduled nature limits inferences about current confidence.

CEO Wang Feng-Ming sold 36,000 shares for $1,975,243.35 amid 32.9% revenue decline and negative annual net income of $-34.9M

CEO Wang Feng-Ming executed 2 separate sales totaling 36,000 shares for $1,975,243.35 on 2024-09-04 and 2024-09-05 at blended average price $54.87, reducing holdings by 4.3% to 803.6K shares. This sale occurred against a backdrop of significant operational deterioration: annual revenue declined 32.9% and the company reported a full-year net income of $-34.9M, compounded by a recent quarterly loss of $-34.9M on $63.7M revenue. The stock has lost 20.3% from its 52-week high of $65.30, though it rallied 30.8% over the past 30 days from deeper lows. The sale by the CEO during a period of sustained unprofitability and substantial revenue contraction, even at a price above current levels of $52.05, warrants close monitoring of whether this reflects capital deployment decisions or a broader shift in executive positioning.